Search

Search Constraints

You searched for: Author/Creator Maehara, Osamu

Search Results

1. Analysis of the optimal psoas muscle mass index cut‐off values, as measured by computed tomography, for the diagnosis of loss of skeletal muscle mass in Japanese people. Issue 6 (7th April 2020)

2. Anti‐adipogenic and antiviral effects of l‐carnitine on hepatitis C virus infection. Issue 5 (3rd October 2016)

3. Baseline angiopoietin‐2 and FGF19 levels predict treatment response in patients receiving multikinase inhibitors for hepatocellular carcinoma. Issue 5 (11th April 2020)

4. Changes in the estimated renal function after hepatitis C virus eradication with direct‐acting antiviral agents: Impact of changes in skeletal muscle mass. Issue 5 (24th February 2021)

5. Computed tomography, not bioelectrical impedance analysis, is the proper method for evaluating changes in skeletal muscle mass in liver disease. Issue 2 (15th July 2020)

6. Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria. Issue 9 (20th July 2021)

7. Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting. Issue 1 (10th June 2019)

8. Effects of resistance‐associated variants in genotype 2 hepatitis C virus on viral replication and susceptibility to antihepatitis C virus drugs. Issue 11 (23rd July 2019)

9. Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis. Issue 11 (25th July 2019)

10. Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats. (24th December 2018)